Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It did for a split second...maybe this week we will break and sustain $100
Anyone think they'll do a forward split at some point (might be a good thing?)
What a after hours...I guess orphan drug designation could come between now and next month and P3 study could begin relatively soon
Moving on up...Glad I held on.
Could happen sooner than I thought
Could challenge its 52 week high by end of Summer.
Nice consolidation after huge move.
ANVS has been sweet. With the right news, these biotechs will run as hard as a meme stock
For new owners of annovis..
Our CEO has sold Companies before
and is well aware of the value of partnerships.
The float is only 4-5 million shares so there is the possibility that a multiple of
That number is SHORT in the market place.
It will be difficult for institutional buyers not to own a piece of such an increddible drug..
New Confirmatory clinical news will be occurring over the next few months..imo
Still well undervalued..imo
Thx for posting
Clay did a good video here. Especially at around the 51 second mark where he does that arrow thing. It is a big red arrow, for a reason. The price over the next several weeks or month and a half will try to close the gap. I do not think it will close it but still, that is so far down there.
Agree I’m not going to lie sold some today but I’m playing with only house money now. I may increase my position but in the short term I’m looking at SLS for their phase 3 data peak on June 3rd.
CEO live tomorrow. There are links to sign up in the press release on their website. Don't know if it will move the stock price, but after the past couple of days, I'll take anything.
Thu, 20 May 2021
BERWYN, PA., May 20, 2021 -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced CEO Maria L. Maccecchini , Ph.D., will participate in the Alzheimer Disease Panel, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday May 26th, 2021 at 11:00 a.m. ET.
Any news on the next thing that will make this pop !?
Yes very good news!
Few shares..
enough clinical
Money to get through phase 3..
* * $ANVS Video Chart 05-24-2021 * *
Link to Video - click here to watch the technical chart video
It allows for a quicker approval process as the patients should be easier to recruit for phase 3 (inclusion criteria are more defined for Down Syndrom patients. Besides, they are a rather large population).
Annovis will also very probably get Orphan Drug designation.
can somebody elaborate or post info to explain the company's strategy for the capital raise and their targeting of AD in down syndrome.
Price predictions?
Company will have an extra $50M cash later this week.
Hedge funds, University endowment funds, pension plans, and mutual funds and other tutes loading shares.
The OS will increase by 1M. I see the super low trading float still at around 4M or even less. ANVS will move up with ease.
Plus an announcement of big Pharma that may do a joint venture, creating huge upside value!!!!!
The offering will close in 72 hours. > May 26, 2021 > Annovis Bio Priced 1M Share Public Offering @$50/Share
6:42 pm ET May 23, 2021 (Benzinga) Print
Annovis Bio (NYSE: ANVS) today announced the pricing of its underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $50.00 per share, for gross proceeds of $50,000,000, before deducting underwriting discounts, commissions and offering expenses. All of the shares of common stock are being offered by the Company.
The offering is expected to close on May 26, 2021, subject to satisfaction of customary closing conditions.
ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering and Maxim Group LLC is acting as co-manager for the offering.
The Company intends to use the net proceeds from the offering primarily for general corporate purposes, including working capital, research and development, capital expenditures and the completion of our planned Phase 3 clinical trial for ANVS401 in AD in persons with Down Syndrome
This is good news correct ?
Seems like we could soar tmw
The offering is only 1 million shares at $50
Offering is out? Isn’t it like 50 for 1 million shares ?
it depends on the offering, it could deep to 40s where I ll be reloading again :)
Price target for Monday ?
I hit the sell on some but have plenty left
Personally we close above 100
The beauty of Anavex is there is no
Competition. Every disease starts with cellular imbalance.. so cellular homeostasis is the Alpha drug.
However ,
Annovis does have an incredible drug
That saves nerves.. I believe the combination of the two
Can save many many people.
Some disagree..
I would like to see some preclinical work in transgenic mouse models
McM what are your thoughts (or anybodys) on this post. I am a little behind in this sector.
Bourbon_on_my_cornflakes Friday, 05/21/21 06:49:11 PM
Re: None 0
Post #
311006
of 311051
WHAT IS THE P-VALUE THE FDA REQUIRES??????
"the ANVS401-treated group compared to the placebo group at 25 days showed an improvement of 3.3 points, or 22% (p= 0.13)."
ISN'T P-VAL OF 0.05 OR LESS NORMALLY REQUIRED BY THE FDA??????
MAYBE SOME WALNUTS WOULD HELP?????
Not a threat to AVXL?
Great company..
Ceo has already started and sold one biopharm..
Will always keep the shorts and longs guessing..
Is it for sale or isn’t it?
Haha.. good luck to longs!!!!!
just kidding McMagyar, but now there are eyeballs on this thing, for good or ill.
Axonal Transport for Alzheimer? Interesting.
Hurry up, millions to make using Grandma as a lab mouse!
Public offering. That’s why it dropped! Never fails to fxck up a great run!
Wouldn’t worry we will hit 200 plus watch.
You will be in gravy by EOY..
bought 4700 shares avg price 94.23. I think I want my money back.
* * $ANVS Video Chart 05-21-2021 * *
Link to Video - click here to watch the technical chart video
Followers
|
46
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
354
|
Created
|
02/04/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |